Beyond ENO1, emerging roles and targeting strategies of other enolases in cancers

Aerobic glycolysis is a hallmark property of cancer metabolism. Enolase is a glycolytic enzyme that catalyzes the conversion of 2-phosphoglycerate into phosphoenolpyruvate. In mammals, enolases exist in three isoforms, encoded by the genes ENO1, ENO2, and ENO3. The altered expression of enolases is...

Full description

Bibliographic Details
Main Authors: Jiaojiao Ni, Yihui Huang, Chaoqun Li, Qian Yin, Jieer Ying
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:Molecular Therapy: Oncolytics
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2372770523000992
_version_ 1797454380628180992
author Jiaojiao Ni
Yihui Huang
Chaoqun Li
Qian Yin
Jieer Ying
author_facet Jiaojiao Ni
Yihui Huang
Chaoqun Li
Qian Yin
Jieer Ying
author_sort Jiaojiao Ni
collection DOAJ
description Aerobic glycolysis is a hallmark property of cancer metabolism. Enolase is a glycolytic enzyme that catalyzes the conversion of 2-phosphoglycerate into phosphoenolpyruvate. In mammals, enolases exist in three isoforms, encoded by the genes ENO1, ENO2, and ENO3. The altered expression of enolases is a common occurrence in various types of cancer. Although most published studies on enolases have predominantly focused on the role of ENO1 in cancer, ENO2 and ENO3 have recently emerged as crucial regulatory molecules in cancer development. Significant progress has been made in understanding their multifaceted roles in oncogenesis. In this comprehensive review, we provide an overview of the structure, subcellular localization, diagnostic and prognostic significance, biological functions, and molecular mechanisms of ENO2 and ENO3 in cancer progression. The importance of enolase in cancer development makes it a novel therapeutic target for clinical applications. Furthermore, we discuss anticancer agents designed to target enolases and summarize their anticancer efficacy in both in vitro and in vivo studies.
first_indexed 2024-03-09T15:36:24Z
format Article
id doaj.art-c7ff07d6b025486c97653f14157d05a6
institution Directory Open Access Journal
issn 2372-7705
language English
last_indexed 2024-03-09T15:36:24Z
publishDate 2023-12-01
publisher Elsevier
record_format Article
series Molecular Therapy: Oncolytics
spelling doaj.art-c7ff07d6b025486c97653f14157d05a62023-11-26T05:13:05ZengElsevierMolecular Therapy: Oncolytics2372-77052023-12-0131100750Beyond ENO1, emerging roles and targeting strategies of other enolases in cancersJiaojiao Ni0Yihui Huang1Chaoqun Li2Qian Yin3Jieer Ying4Department of Hepato-Pancreato-Biliary & Gastric Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, China; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310018, ChinaDepartment of Medical Oncology, The Second Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310000, ChinaWenzhou Medical University, Wenzhou, Zhejiang 325088, ChinaWenzhou Medical University, Wenzhou, Zhejiang 325088, ChinaDepartment of Hepato-Pancreato-Biliary & Gastric Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, China; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310018, China; Corresponding author: Jieer Ying, No. 1, East Banshan Road, Gongshu District, Hangzhou, Zhejiang 310022, China.Aerobic glycolysis is a hallmark property of cancer metabolism. Enolase is a glycolytic enzyme that catalyzes the conversion of 2-phosphoglycerate into phosphoenolpyruvate. In mammals, enolases exist in three isoforms, encoded by the genes ENO1, ENO2, and ENO3. The altered expression of enolases is a common occurrence in various types of cancer. Although most published studies on enolases have predominantly focused on the role of ENO1 in cancer, ENO2 and ENO3 have recently emerged as crucial regulatory molecules in cancer development. Significant progress has been made in understanding their multifaceted roles in oncogenesis. In this comprehensive review, we provide an overview of the structure, subcellular localization, diagnostic and prognostic significance, biological functions, and molecular mechanisms of ENO2 and ENO3 in cancer progression. The importance of enolase in cancer development makes it a novel therapeutic target for clinical applications. Furthermore, we discuss anticancer agents designed to target enolases and summarize their anticancer efficacy in both in vitro and in vivo studies.http://www.sciencedirect.com/science/article/pii/S2372770523000992ENO1ENO2ENO3neuron-specific enolasetumor glycolysisbiomarker
spellingShingle Jiaojiao Ni
Yihui Huang
Chaoqun Li
Qian Yin
Jieer Ying
Beyond ENO1, emerging roles and targeting strategies of other enolases in cancers
Molecular Therapy: Oncolytics
ENO1
ENO2
ENO3
neuron-specific enolase
tumor glycolysis
biomarker
title Beyond ENO1, emerging roles and targeting strategies of other enolases in cancers
title_full Beyond ENO1, emerging roles and targeting strategies of other enolases in cancers
title_fullStr Beyond ENO1, emerging roles and targeting strategies of other enolases in cancers
title_full_unstemmed Beyond ENO1, emerging roles and targeting strategies of other enolases in cancers
title_short Beyond ENO1, emerging roles and targeting strategies of other enolases in cancers
title_sort beyond eno1 emerging roles and targeting strategies of other enolases in cancers
topic ENO1
ENO2
ENO3
neuron-specific enolase
tumor glycolysis
biomarker
url http://www.sciencedirect.com/science/article/pii/S2372770523000992
work_keys_str_mv AT jiaojiaoni beyondeno1emergingrolesandtargetingstrategiesofotherenolasesincancers
AT yihuihuang beyondeno1emergingrolesandtargetingstrategiesofotherenolasesincancers
AT chaoqunli beyondeno1emergingrolesandtargetingstrategiesofotherenolasesincancers
AT qianyin beyondeno1emergingrolesandtargetingstrategiesofotherenolasesincancers
AT jieerying beyondeno1emergingrolesandtargetingstrategiesofotherenolasesincancers